In 2001, Genentech had 535.3 million average common shares outstanding, actual shares outstanding at year-end of 528.3 million and reported earnings per share of $.28. Genentech's reported net income in 2001 equals
A) $149.9 million.
B) $147.9 million.
C) $148.9 million.
D) an amount that cannot be computed with the given information.